Related Experiment Videos
Active GPIIb-IIIa conformations that link ligand interaction with cytoskeletal reorganization
T H Mondoro1, M M White, L K Jennings
1Vascular Biology Program, University of Tennessee, Memphis, TN, USA.
Blood
|September 26, 2000
Summary
Glycoprotein (GP) IIb-IIIa mediates platelet aggregation and clot retraction. This study shows that while GP IIb-IIIa ligand binding is essential, clot retraction requires further signaling post-binding.
Area of Science:
- Hematology
- Molecular Biology
- Cell Biology
Background:
- Glycoprotein (GP) IIb-IIIa is crucial for platelet aggregation and clot retraction.
- Understanding the distinct roles of GP IIb-IIIa activation states is vital for thrombosis research.
Purpose of the Study:
- To investigate the relationship between GP IIb-IIIa activation, fibrinogen binding, platelet aggregation, and clot retraction.
- To differentiate high-affinity GP IIb-IIIa activation states using a specific antibody (D3).
Main Methods:
- Utilized antibody D3, specific for GPIIIa, to probe GP IIb-IIIa activation states.
- Assessed fibrinogen binding, platelet aggregation, and clot retraction.
- Analyzed cytoskeletal incorporation and platelet morphology.
Main Results:
- Antibody D3 binding to GP IIb-IIIa did not alter platelet-fibrin interactions but inhibited clot retraction.
- Combined D3 and adenosine diphosphate (ADP) treatment reduced full-scale aggregation and cytoskeletal protein incorporation.
- ADP addition increased D3 binding sites, indicating ligand engagement with the GP IIb-IIIa receptor.
Conclusions:
- High-affinity GP IIb-IIIa ligand binding can be mechanistically separated from GP IIb-IIIa-mediated clot retraction.
- Clot retraction necessitates additional signaling through GP IIb-IIIa subsequent to ligand binding.
- The D3-recognized conformation signifies a GP IIb-IIIa activation state involved in aggregation, cytoskeletal reorganization, and clot retraction.